1-16 of 16
Keywords: Newborn screening
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles
Journal Articles
Journal Articles
Public Health Genomics (2020) 23 (5-6): 184–189.
Published Online: 10 December 2020
... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Health policy GJB2 -R143W founder mutation Hearing impairment Newborn screening Ghana UKRI (UK Research and Innovation) Review Article Public Health...
Journal Articles
Journal Articles
Public Health Genomics (2014) 17 (3): 141–148.
Published Online: 03 April 2014
...Chinmayee B. Nagaraj; Erin Rothwell; Kimberly Hart; Seth Latimer; Joshua D. Schiffman; Jeffrey R. Botkin Background/Objectives: Studies have shown that the general public is supportive of newborn screening (NBS) and supportive of the storage and use of residual bloodspots for quality assurance...
Journal Articles
Journal Articles
Public Health Genomics (2012) 15 (3-4): 146–155.
Published Online: 04 April 2012
... and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Biobank Informed consent Michigan BioTrust for Health Newborn screening Residual dried blood spots For more...
Journal Articles
Public Health Genomics (2011) 14 (3): 173–177.
Published Online: 18 December 2010
...D.R. Morrison; E.W. Clayton Objective: Our goal was to assess the impact on families of receiving abnormal newborn screening results. Patients and Methods: We conducted telephone interviews with parents of 3 groups of children who had received abnormal newborn screening results: (1) false positive...
Journal Articles
Public Health Genomics (2011) 14 (3): 143–152.
Published Online: 18 December 2010
...D. Duquette; A.P. Rafferty; C. Fussman; J. Gehring; S. Meyer; J. Bach Objectives: The level of support among Michigan adults for the use of residual newborn screening dried blood spots (DBS) was investigated. Methods: We analyzed data from 4 questions on the 2008 Michigan Behavioral Risk Factor...
Journal Articles
Journal Articles
Public Health Genomics (2010) 13 (3): 171–180.
Published Online: 16 October 2009
... screening and diagnosis on the birth prevalence of congenital anomalies is limited by gaps and variations in surveillance systems. Newborn screening programs are almost inexistent. There is broad variation in optional participation in laboratory quality assurance schemes, and there are no regulatory...
Journal Articles
Public Health Genomics (2010) 13 (3): 181–190.
Published Online: 22 September 2009
...F.A. Miller; R.Z. Hayeems; J.C. Carroll; B. Wilson; J. Little; J. Allanson; J.P. Bytautas; M. Paynter; R. Christensen; P. Chaktraborty Background: As newborn screening (NBS) expands to meet a broader definition of benefit, the scope of parental consent warrants reconsideration. Methods: We...
Journal Articles
Public Health Genomics (2010) 13 (5): 269–275.
Published Online: 22 September 2009
... economically advanced cities. Newborn screening programs are mandated throughout the country but vary between provinces and territories in terms of organization and diseases screened for; most screening tests are paid by out-of-pocket expenses. Genetic tests are encouraged while there are only one accredited...
Journal Articles
Public Health Genomics (2009) 13 (2): 106–115.
Published Online: 29 June 2009
... cost of resources expended. Methods: We review current evidence-based processes used in the United States, the United Kingdom, and the Netherlands to assess genetic screening programs, including newborn screening programs, carrier screening, and organized cascade testing of relatives of patients...
Journal Articles
Public Health Genomics (2008) 12 (2): 112–120.
Published Online: 14 September 2008
... of routine clinical prenatal services with variable uptake. Surveillance of the effect of prenatal screening and diagnosis on the birth prevalence of congenital anomalies is limited by gaps and variations in surveillance systems. Newborn screening programs vary between provinces and territories in terms...
Journal Articles
Public Health Genomics (2008) 12 (2): 67–72.
Published Online: 14 September 2008
...B.K. Yoo; S.D. Grosse Objective: To assess the cost effectiveness of newborn screening for congenital adrenal hyperplasia (CAH) in the U.S. newborn population. Methods: We constructed a decision model to estimate the incremental cost-effectiveness ratio (ICER) of CAH screening compared...